Sentry Data Systems is a technology company founded in 2003 by Travis Leonardi that uses analytics to help over 11,000 healthcare organizations meet safety net obligations. The company provides automated pharmacy tools and helps clients comply with the 340B drug pricing program, which allows discounts on outpatient drugs for eligible healthcare sites. Sentry assists with 340B program requirements set by the Health Resources and Services Administration such as maintaining accurate records, audit preparation, and ensuring no duplicate discounts or diversion of drugs to ineligible patients.

1. Sentry Data Sytems and 340B
compliance
By: Travis Leonardi

2. Sentry Data Sytems and 340B compliance
Holding a degree in pharmacy from St. Johns University in New York, New York, Travis Leonardi
has over 15 years of experience with health care business technology services. Travis Leonardi
founded his company, Sentry Data Systems, in 2003, in Deerfield Beach, Florida.

3. Sentry Data Sytems and 340B compliance
Sentry Data Systems (SDS) is a technology business that uses comparative rapid-cycle analytics
to improve health care quality and reduce the total cost of care. The company integrates more than
11,000 hospitals, clinics, and pharmacies across the US, helping them to meet the safety net
mission needed for serving communities. SDS is considered a pioneer in automated pharmacy
procurement, 340B compliance, and utilization management.

4. Sentry Data Sytems and 340B compliance
The 340B compliance, or the 340B drug pricing program, has been managed by the Health
Resources and Services Administration (HRSA) since 1992. Participants in this program can
improve their services to patients through access to a significant discount on qualifying outpatient
medication purchases.

5. Sentry Data Sytems and 340B compliance
HRSA designates some requirements for eligibility to 340B compliance, such as the maintenance
of accurate 340B database information, eligibility recertification, preparation for program audits,
and a commitment to the prevention of duplicate discounts and diversion to ineligible patients.